CSHL Cancer Center Archives | ��ϳԹ��Դ

A Closer Look: CSHL’s Microscopy Core

Communications Department — Mon, 30 Mar 2026 11:30:28 +0000

The post A Closer Look: CSHL’s Microscopy Core appeared first on ��ϳԹ��Դ.

New mass spec innovation could transform research

Nick Wurm — Tue, 06 Jan 2026 17:00:39 +0000

Weight says a lot. In the kitchen, it could mean cooking with too little or too much of an ingredient. For scientists, a molecule’s weight can help determine its makeup. This, in turn, can shed light on whether a potential drug is acting on the body or not working at all. Weight can even reveal...

The post New mass spec innovation could transform research appeared first on ��ϳԹ��Դ.

On the trail of a cellular cold case

Nick Wurm — Tue, 16 Dec 2025 17:00:43 +0000

If you remember high school biology, you know cells pack a lot inside a tiny package. Inside the nucleus of every one of our cells, you’ll see more than a few things floating around. You may be familiar with RNA and DNA. But that’s not all you’ll find there. Over a century ago, scientists discovered...

The post On the trail of a cellular cold case appeared first on ��ϳԹ��Դ.

NCI grants support ‘natural’ cancer research

Margaret Osborne — Mon, 11 Aug 2025 11:30:42 +0000

Complex chemical and biological processes are fundamental for all life on Earth and all the organs inside us. When something goes wrong with these processes, diseases like cancer can arise. At the ��ϳԹ��Դ (CSHL) Cancer Center, Professor John Moses and colleagues use click chemistry, a fast and reliable technique for linking molecules,...

The post NCI grants support ‘natural’ cancer research appeared first on ��ϳԹ��Դ.

In pancreatic cancer, a race against time

Samuel Diamond — Wed, 02 Apr 2025 04:05:05 +0000

Cancer Research and conducted with generous support from the Lustgarten Foundation, shows that inhibiting the FGFR2 and EGFR proteins in pancreatic cells can delay or even prevent tumor formation." data-description="" />AI generated voice with David Tuveson’s actual voice Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it’s diagnosed, it’s often difficult to treat. So, for both individual patients and the general population, fighting pancreatic cancer can feel like a race against time. ��ϳԹ��Դ (CSHL) Professor and...

The post In pancreatic cancer, a race against time appeared first on ��ϳԹ��Դ.

Aboff’s Paints donates $50K to CSHL breast cancer research

Caroline Cosgrove — Tue, 25 Feb 2025 17:00:11 +0000

Long Island, N.Y., has one of the highest breast cancer rates in the United States. Scientists at ��ϳԹ��Դ (CSHL), a National Cancer Institute-designated Cancer Center on Long Island’s North Shore, are dedicated to research aimed at developing new diagnostics and therapies for breast cancer. But these breakthroughs are only possible with strong...

The post Aboff’s Paints donates $50K to CSHL breast cancer research appeared first on ��ϳԹ��Դ.

‘Is cancer immunotherapy right for me?’

Communications Department — Tue, 21 Jan 2025 12:30:40 +0000

The post ‘Is cancer immunotherapy right for me?’ appeared first on ��ϳԹ��Դ.

A speckle of hope for cancer patients

Luis Sandoval — Thu, 02 Jan 2025 10:00:42 +0000

Nature Cell Biology. " data-description="" />AI generated voice with Kate Alexander’s actual voice Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to explain why. Now, ��ϳԹ��Դ (CSHL) Assistant Professor Katherine Alexander and University of...

The post A speckle of hope for cancer patients appeared first on ��ϳԹ��Դ.

CSHL and Range ETFs launch new partnership

Lisa Cruz — Thu, 21 Nov 2024 12:30:49 +0000

More than two million new cases of cancer will be diagnosed in the United States in 2024, according to the National Cancer Institute. Range Cancer Therapeutics ETF (Nasdaq: CNCR) is partnering with ��ϳԹ��Դ (CSHL) to highlight CSHL’s pioneering role in advancing cancer research. Through the partnership, 23% of revenues generated by fees...

The post CSHL and Range ETFs launch new partnership appeared first on ��ϳԹ��Դ.

Cocktails & Chromosomes: The whole-body health spectrum

Communications Department — Thu, 22 Aug 2024 16:00:46 +0000

The post Cocktails & Chromosomes: The whole-body health spectrum appeared first on ��ϳԹ��Դ.

Wrexham University awards John Moses Honorary Fellowship

Luis Sandoval — Thu, 13 Jun 2024 11:30:25 +0000

They say you can’t go home again. Try telling that to ��ϳԹ��Դ (CSHL) Professor John Moses. The chemist recently returned to his hometown of Wrexham, a city in the northeast corner of Wales, near the country’s border with England. There, he received a hero’s welcome as he was awarded an Honorary Fellowship...

The post Wrexham University awards John Moses Honorary Fellowship appeared first on ��ϳԹ��Դ.

CSHL and Northwell Health extend strategic affiliation

Phil Renna — Mon, 29 Apr 2024 13:30:22 +0000

The historic agreement aims to translate basic bioscience into a clinical setting, providing cancer patients with greater access to personalized healthcare. NEW YORK, NY — Leaders from two of New York’s preeminent bioscience and healthcare institutions came together at Carnegie Hall to acknowledge the signing of an update to their affiliation agreement initiated in 2015....

The post CSHL and Northwell Health extend strategic affiliation appeared first on ��ϳԹ��Դ.

Tuveson elected to American Academy of Arts & Sciences

Nick Wurm — Wed, 24 Apr 2024 16:00:11 +0000

��ϳԹ��Դ (CSHL) Professor and Cancer Center Director David Tuveson has been elected to the American Academy of Arts and Sciences. He is one of 250 new members elected to the venerable institution in 2024. Tuveson is a pioneer in cancer research. His groundbreaking work with cancer organoids—miniature versions of tumors—led to the...

The post Tuveson elected to American Academy of Arts & Sciences appeared first on ��ϳԹ��Դ.

Better cancer trials could be around the corner

Nick Wurm — Thu, 21 Mar 2024 15:00:18 +0000

��ϳԹ��Դ Associate Professor and Cancer Center member Tobias Janowitz led a COVID-19 clinical trial with Northwell Health in 2021. When he and Clinical Fellow Hassal Lee reviewed the data, a surprising trend emerged. “The patient roster was very diverse,” Janowitz explains. “We’d made no deliberate effort toward that other than conducting the...

The post Better cancer trials could be around the corner appeared first on ��ϳԹ��Դ.

Joshua-Tor named CSHL Director of Research

Samuel Diamond — Tue, 02 Jan 2024 12:35:35 +0000

��ϳԹ��Դ (CSHL) Professor and HHMI Investigator Leemor Joshua-Tor has been named CSHL Director of Research. She takes over the position effective January 2, 2024. Research at CSHL explores the frontiers of cancer, neuroscience, genomics, quantitative biology, and plant biology. The Joshua-Tor lab, one of more than 60 at CSHL, studies gene expression...

The post Joshua-Tor named CSHL Director of Research appeared first on ��ϳԹ��Դ.

Test your breast cancer awareness

Communications Department — Wed, 18 Oct 2023 11:30:33 +0000

{“questions”:{“equ3q”:{“id”:”equ3q”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:”https:\/\/www.cshl.edu\/wp-content\/uploads\/2019\/12\/novel-therapy-target-triple-negative-breast-cancer.jpg”,”imageId”:”36481″,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Some breast cancers lack two key hormone receptors as well as the HER2 receptor. What is this type of breast cancer called?”,”desc”:”In triple-negative breast cancer, the cancer cells don\u2019t have estrogen, progesterone, or HER2 receptors. As a result, this kind of cancer is very difficult to treat. CSHL Professor John Moses and Assistant Professor Michael...

The post Test your breast cancer awareness appeared first on ��ϳԹ��Դ.

Zhen Zhao

Marc Persad — Wed, 27 Sep 2023 14:28:56 +0000

The post Zhen Zhao appeared first on ��ϳԹ��Դ.

CSHL announces AACR Cancer Centers Alliance

Nick Wurm — Mon, 18 Sep 2023 11:30:32 +0000

��ϳԹ��Դ (CSHL) Professor and Cancer Center Director David Tuveson has announced the launch of the American Association for Cancer Research (AACR) Cancer Centers Alliance. The new initiative will foster collaboration and innovation to advance lifesaving scientific discoveries. With Tuveson as the founding chair of the AACR group’s steering committee, CSHL’s Cancer Center...

The post CSHL announces AACR Cancer Centers Alliance appeared first on ��ϳԹ��Դ.

In cancer immunotherapy, more isn’t necessarily better

Margaret Osborne — Thu, 14 Sep 2023 15:00:50 +0000

DNA mismatch repair deficiency (MMRd) is a genetic condition often associated with colon cancer. It can happen in otherwise normal cells before cancer forms or after a tumor has already formed. The condition makes it hard for cells to correct mistakes that occur in DNA copying. This can lead to many mutations within tumors, or...

The post In cancer immunotherapy, more isn’t necessarily better appeared first on ��ϳԹ��Դ.

CSHL makes a splash with Swim Across America

Communications Department — Mon, 21 Aug 2023 11:30:26 +0000

The post CSHL makes a splash with Swim Across America appeared first on ��ϳԹ��Դ.

CSHL Cancer Center Archives | ���ϳԹ���Դ